VASCULAR SUPEROXIDE-DISMUTASE DEFICIENCY IMPAIRS ENDOTHELIAL VASODILATOR FUNCTION THROUGH DIRECT INACTIVATION OF NITRIC-OXIDE AND INCREASEDLIPID-PEROXIDATION
Sm. Lynch et al., VASCULAR SUPEROXIDE-DISMUTASE DEFICIENCY IMPAIRS ENDOTHELIAL VASODILATOR FUNCTION THROUGH DIRECT INACTIVATION OF NITRIC-OXIDE AND INCREASEDLIPID-PEROXIDATION, Arteriosclerosis, thrombosis, and vascular biology, 17(11), 1997, pp. 2975-2981
Nitric oxide (NO) and superoxide are both constitutive products of the
endothelium. Because NO is readily inactivated by superoxide, the bio
activity of endothelium-derived NO (EDNO) is dependent on local activi
ty of superoxide dismutase (SOD). We examined the effects of chronic i
nhibition of copper-zinc SOD (CuZnSOD) using a rat model of dietary co
pper restriction. Male weanling Sprague-Dawley rats were fed a Cu-defi
cient diet and received either no Cu replacement (Cu-deficient) or Cu
in the drinking water (Cu-sufficient). Compared with Cu-sufficient ani
mals, Cu-deficiency was associated with a 68% reduction in CuZnSOD act
ivity and a 58% increase in vascular superoxide as estimated by lucige
nin chemiluminescence (both P<.05). Compared with Cu-sufficient animal
s, arterial relaxation in the thoracic aorta from Cu-deficient animals
was 10-fold less sensitive to acetylcholine, a receptor-dependent EDN
O agonist, but only 1.5-fold less sensitive to A23187, a receptor-inde
pendent EDNO agonist, and only 1.25-fold less sensitive to authentic N
O (all P<.05). In contrast, acute inhibition of CuZnSOD with 10 mM die
thyldithiocarbamate produced a more uniform reduction in sensitivity t
o acetylcholine (8-fold), A23187 (10-fold), and NO (4-fold; all P<.001
). Cu-deficient animals demonstrated a 2.5-fold increase in plasma-est
erified F-2-isoprostanes, a stable marker of lipid peroxidation, that
correlated inversely with arterial relaxation to acetylcholine (R=-.83
, P<.0009) but not A23187 or authentic NO. From these findings, we con
clude that chronic inhibition of CuZnSOD inhibits EDNO-mediated arteri
al relaxation through two mechanisms, one being direct inactivation of
NO and the other being lipid peroxidation that preferentially interru
pts receptor-mediated stimulation of EDNO.